Cargando…

Therapeutic Potential of the Cyclin-Dependent Kinase Inhibitor Flavopiridol on c-Myc Overexpressing Esophageal Cancer

Tumors with elevated c-Myc expression often exhibit a highly aggressive phenotype, and c-Myc amplification has been shown to be frequent in esophageal cancer. Emerging data suggests that synthetic lethal interactions between c-Myc pathway activation and small molecules inhibition involved in cell cy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hassan, Md Sazzad, Cwidak, Nicholas, Johnson, Chloe, Däster, Silvio, Eppenberger-Castori, Serenella, Awasthi, Niranjan, Li, Jun, Schwarz, Margaret A., von Holzen, Urs
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490822/ https://www.ncbi.nlm.nih.gov/pubmed/34621175 http://dx.doi.org/10.3389/fphar.2021.746385

Ejemplares similares

Cytokine Interaction With Cancer-Associated Fibroblasts in Esophageal Cancer
por: Hassan, Md Sazzad, et al.
Publicado: (2022)

A novel intraperitoneal metastatic xenograft mouse model for survival outcome assessment of esophageal adenocarcinoma
por: Hassan, Md. Sazzad, et al.
Publicado: (2017)

Combination effect of lapatinib with foretinib in HER2 and MET co-activated experimental esophageal adenocarcinoma
por: Hassan, Md. Sazzad, et al.
Publicado: (2019)

Superior Therapeutic Efficacy of Nanoparticle Albumin Bound Paclitaxel Over Cremophor-Bound Paclitaxel in Experimental Esophageal Adenocarcinoma
por: Hassan, Md Sazzad, et al.
Publicado: (2018)

Nab-Paclitaxel in the Treatment of Gastrointestinal Cancers—Improvements in Clinical Efficacy and Safety
por: Hassan, Md Sazzad, et al.
Publicado: (2023)

Low Expression of Programmed Death 1 (PD-1), PD-1 Ligand 1 (PD-L1), and Low CD8+ T Lymphocyte Infiltration Identify a Subgroup of Patients With Gastric and Esophageal Adenocarcinoma With Severe Prognosis
por: Däster, Silvio, et al.
Publicado: (2020)

Targeting KRAS for the potential treatment of pancreatic ductal adenocarcinoma: Recent advancements provide hope (Review)
por: Zhang, Joshua, et al.
Publicado: (2023)

Increased Level of Phosphorylated ShcA Measured by Chemiluminescence-Linked Immunoassay Is a Predictor of Good Prognosis in Primary Breast Cancer Expressing Low Levels of Estrogen Receptor
por: Cicenas, Jonas, et al.
Publicado: (2010)

Increased level of phosphorylated akt measured by chemiluminescence-linked immunosorbent assay is a predictor of poor prognosis in primary breast cancer overexpressing ErbB-2
por: Cicenas, Jonas, et al.
Publicado: (2005)

The cyclin-dependent kinase inhibitor flavopiridol (alvocidib) inhibits metastasis of human osteosarcoma cells
por: Zocchi, Loredana, et al.
Publicado: (2018)

Targeted dual inhibition of c‐Met/VEGFR2 signalling by foretinib improves antitumour effects of nanoparticle paclitaxel in gastric cancer models
por: Grojean, Meghan, et al.
Publicado: (2021)

High Frequency of CD8 Positive Lymphocyte Infiltration Correlates with Lack of Lymph Node Involvement in Early Rectal Cancer
por: Däster, Silvio, et al.
Publicado: (2014)

Flavopiridol Mitigates the Progression of Monocrotaline-Induced Pulmonary Hypertension in Rats by Targeting Cyclin-Dependent Kinase 9
por: Jia, Qi, et al.
Publicado: (2022)

The radiation-sensitizing effect of flavopiridol in the esophageal cancer cell line Eca109
por: YAO, YUAN, et al.
Publicado: (2013)

Antitumor effects of flavopiridol, a cyclin-dependent kinase inhibitor, on human cholangiocarcinoma in vitro and in an in vivo xenograft model
por: Saisomboon, Saowaluk, et al.
Publicado: (2019)

Potent interaction of flavopiridol with MRP1
por: Hooijberg, J H, et al.
Publicado: (1999)

Effect of P-glycoprotein on flavopiridol sensitivity
por: Boerner, S A, et al.
Publicado: (2001)

The Pharmacological Implications of Flavopiridol: An Updated Overview
por: Joshi, Hemant, et al.
Publicado: (2023)

OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer
por: Weixler, Benjamin, et al.
Publicado: (2015)

Risk Factors for Tumor Lysis Syndrome in patients with Chronic Lymphocytic Leukemia Treated with the Cyclin Dependent Kinase Inhibitor, Flavopiridol
por: Blum, Kristie A., et al.
Publicado: (2011)

Flavopiridol (Alvocidib), a Cyclin-dependent Kinases (CDKs) Inhibitor, Found Synergy Effects with Niclosamide in Cutaneous T-cell Lymphoma
por: Zhang, Xu Hannah, et al.
Publicado: (2021)

Comparison of gene expression profiles in core biopsies and corresponding surgical breast cancer samples
por: Zanetti-Dällenbach, Rosanna, et al.
Publicado: (2006)

Transgenic models are predictive: the herceptin and flavopiridol experience
por: Schmidt, E
Publicado: (2003)

Flavopiridol Pharmacogenetics: Clinical and Functional Evidence for the Role of SLCO1B1/OATP1B1 in Flavopiridol Disposition
por: Ni, Wenjun, et al.
Publicado: (2010)

Complex effects of flavopiridol on the expression of primary response genes
por: Keskin, Havva, et al.
Publicado: (2012)

Enhanced NFκB and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer
por: Zhou, Yamei, et al.
Publicado: (2007)

Bone metastases in breast cancer: Frequency, metastatic pattern and non-systemic locoregional therapy
por: Steinauer, Kirsten, et al.
Publicado: (2014)

Low E2F1 transcript levels are a strong determinant of favorable breast cancer outcome
por: Vuaroqueaux, Vincent, et al.
Publicado: (2007)

The angiogenic properties of Kaposi's sarcoma-associated herpesvirus encoded G-protein coupled receptor are reduced by flavopiridol, an inhibitor of cyclin-dependent kinase 9
por: McFerrin, Harris, et al.
Publicado: (2010)

Overexpression of Cyclin D1 in Rat Esophageal Carcinogenesis Model
por: Youssef, Emile M., et al.
Publicado: (1997)

Radiotherapy in patients with distant metastatic breast cancer
por: Steinauer, Kirsten, et al.
Publicado: (2014)

HER2 and uPAR cooperativity contribute to metastatic phenotype of HER2-positive breast cancer
por: Chandran, Vineesh Indira, et al.
Publicado: (2015)

Re-Punching Tissue Microarrays Is Possible: Why Can This Be Useful and How to Do It
por: Lacombe, Aurélien, et al.
Publicado: (2015)

Flavopiridol Protects Bone Tissue by Attenuating RANKL Induced Osteoclast Formation
por: Hu, Zi’ang, et al.
Publicado: (2018)

Distinct Stromal and Immune Features Collectively Contribute to Long-Term Survival in Pancreatic Cancer
por: Sadozai, Hassan, et al.
Publicado: (2021)

Potent inhibition of rhabdoid tumor cells by combination of flavopiridol and 4OH-tamoxifen
por: Cimica, Velasco, et al.
Publicado: (2010)

Metabolic reprogramming is associated with flavopiridol resistance in prostate cancer DU145 cells
por: Li, Xiaoran, et al.
Publicado: (2017)

Plasma HER2ECD a promising test for patient prognosis and prediction of response in HER2 positive breast cancer: results of a randomized study - SAKK 22/99
por: Eppenberger-Castori, Serenella, et al.
Publicado: (2020)

Disturbed alternative splicing of FIR (PUF60) directed cyclin E overexpression in esophageal cancers
por: Ogura, Yukiko, et al.
Publicado: (2018)

Overexpression of cyclin‐dependent kinase 1 in esophageal squamous cell carcinoma and its clinical significance
por: Zhang, Han‐Jie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jo1o20ftnl4c5prdkcbmvf58rt